9 September 2010

COE

Company Details

Address:
Photon House , Percy Street , Leeds LS12 1EG
Telephone:
0113 230 8800
Fax:
0113 279 9229
Email:
sales@coe.co.uk
Website:
www.coe.co.uk

Commentary

Advanced video surveillance systems developer and supplier

Executives

Chairman:
Alison Fielding (1.3% holding)
Chief Executive:
Ian Jefferson (0% holding)
Technical Director:
Mark Marriage (.4% holding)

Main Shareholders

IP2IPO: 38.6%

Evolution Securities Nominees: 11.1%

Bank of New York Nominees: 9.9%

Partnership Investment Equity Fund: 9.1%

COE Group Employment Benefit Trust: 5.5%

Advisers

Nominated Adviser:
Zeus Capital
Nominated Broker:
Zeus Capital
Solicitors:
DLA Piper
Auditors:
PricewaterhouseCoopers
Registrar:
Computershare Investor Services

Accounts Information

Entry on AIM:
5/6/2003
Issue Price:
20.5p
Interim Results:
Mar
Final Results:
Nov
Year End:
Jun
Accounts Due:
Dec
Int div payment:
n/a
Fin div payment:
n/a
Int net div per share:
nil
Fin net div per share:
nil

Financial History

  2009 2008
Turnover: £3.83m £4.18m
Pre-tax profit: £ (0.16m) £ (1.11m)
EPS: 0.0 p (4.7) p

Associated Articles

Cash Shells Directory 2010

A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.

The AIM Guide Spring 2010

The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).

A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!

Popular News

Latest News

Futura hails product progress 08/09/2010

Consumer healthcare concern Futura Medical says it expects European approval this year for its CSD500 erection-maintaining condom.

Tags: AIM , Deals & contracts , Fundraisings , Growth Stocks

Sector: Pharmaceuticals & Biotechnology

Companies: Futura Medical

Dana details bid defence 08/09/2010

Dana Petroleum says its shares are worth between £22.70p and £24.65p to support its opposition to Korea National Oil Corporation's bid at £18.

Tags: Commodities , Full list , Growth Stocks

Sector: Oil & Gas Producers

Companies: Dana Petroleum

Abcam 'cautious' after strong growth 07/09/2010

Online antibody distributor Abcam fears public spending cuts might dampen growth after lifting annual pre-tax profits 58.4 per cent to £25.8 million.

Tags: AIM , Cash , Dividends , Growth Stocks

Sector: Pharmaceuticals & Biotechnology

Companies: Abcam

More News

Sectors

Vitesse Media Events